Literature DB >> 8181498

The favourable effect of cyclophosphamide pulse therapy in the treatment of massive pulmonary haemorrhage in systemic lupus erythematosus.

M Fukuda1, Y Kamiyama, K Kawahara, K Kawamura, T Mori, M Honda.   

Abstract

Pulmonary haemorrhage (PH) is a rare but very serious complication of systemic lupus erythematosus (SLE) and the treatment is still controversial. Some authors showed the effectiveness of methylprednisolone pulse therapy for PH, although its effect was often transient. A 12-year-old Japanese girl with lupus nephritis and recurrent massive PH in SLE was treated with methylprednisolone pulse therapy. The effect on PH was transient and she needed three cycles within a month and side-effects developed. Pulse therapy with cyclophosphamide, synchronized with plasmapheresis, was tried. Thereafter she did not experience PH for 7 months, whereas lupus nephritis did not improve. Pulse cyclophosphamide would be effective for life threatening massive PH in SLE patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8181498     DOI: 10.1007/bf01958977

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  14 in total

1.  [Fatal case of massive pulmonary hemorrhage after a 20-year history of systemic lupus erythematosus].

Authors:  Y Morikawa; T Danbara; T Kanemitsu; K Inatomi; F Yoshimine; S Kira
Journal:  Nihon Kyobu Shikkan Gakkai Zasshi       Date:  1987-11

2.  [An autopsy case of systemic lupus erythematosus complicated by pulmonary hemorrhage].

Authors:  Y Asano; K Nagasawa; Y Tsuda; M Nagano; T Kusaba; Y Niho; K Mimura
Journal:  Nihon Naika Gakkai Zasshi       Date:  1987-03

3.  Pulmonary hemorrhage in pediatric patients with systemic lupus erythematosus.

Authors:  R W Miller; J R Salcedo; R J Fink; T M Murphy; D B Magilavy
Journal:  J Pediatr       Date:  1986-04       Impact factor: 4.406

4.  A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group.

Authors:  E J Lewis; L G Hunsicker; S P Lan; R D Rohde; J M Lachin
Journal:  N Engl J Med       Date:  1992-05-21       Impact factor: 91.245

5.  NIH conference. Lupus nephritis.

Authors:  J E Balow; H A Austin; G C Tsokos; T T Antonovych; A D Steinberg; J H Klippel
Journal:  Ann Intern Med       Date:  1987-01       Impact factor: 25.391

6.  Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis.

Authors:  D T Boumpas; H A Austin; E M Vaughn; J H Klippel; A D Steinberg; C H Yarboro; J E Balow
Journal:  Lancet       Date:  1992-09-26       Impact factor: 79.321

7.  Pulmonary hemorrhage associated with systemic lupus erythematosus in children.

Authors:  R E Ramirez; C Glasier; D Kirks; G D Shackelford; M Locey
Journal:  Radiology       Date:  1984-08       Impact factor: 11.105

8.  Microangiitis in lupus-induced pulmonary hemorrhage.

Authors:  J L Myers; A A Katzenstein
Journal:  Am J Clin Pathol       Date:  1986-05       Impact factor: 2.493

9.  Intermittent intravenous cyclophosphamide therapy for lupus nephritis.

Authors:  T J Lehman; D D Sherry; L Wagner-Weiner; D K McCurdy; H M Emery; D B Magilavy; A Kovalesky
Journal:  J Pediatr       Date:  1989-06       Impact factor: 4.406

10.  Pulmonary hemorrhage and immune-complex deposition in the lung. Complications in a patient with systemic lupus erythematosus.

Authors:  A Churg; W Franklin; K L Chan; E Kopp; C B Carrington
Journal:  Arch Pathol Lab Med       Date:  1980-07       Impact factor: 5.534

View more
  4 in total

Review 1.  Recognition and management of systemic lupus erythematosus.

Authors:  J O Schroeder; H H Euler
Journal:  Drugs       Date:  1997-09       Impact factor: 9.546

Review 2.  Systemic lupus erythematosus.

Authors:  M S Klein-Gitelman; M L Miller
Journal:  Indian J Pediatr       Date:  1996 Jul-Aug       Impact factor: 1.967

3.  Diffuse Alveolar Hemorrhage as a Life-Threatening Feature of Juvenile Onset Systemic Lupus Erythematosus: A Case-Based Review.

Authors:  Belde Kasap-Demir; Gülenay Bayram; Zuhal Önder-Siviş; Burçak Güneş-Tatlı; Berna Ayşe Anıl
Journal:  Mediterr J Rheumatol       Date:  2022-03-31

4.  Ovarian failure in SLE patients using pulse cyclophosphamide: comparison of different regimes.

Authors:  Simone Appenzeller; Paula F Blatyta; Lilian T L Costallat
Journal:  Rheumatol Int       Date:  2007-10-30       Impact factor: 2.631

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.